Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis

Eur J Neurol. 2009 Feb;16(2):262-7. doi: 10.1111/j.1468-1331.2008.02406.x. Epub 2008 Dec 9.

Abstract

Background: Prevalence rates of headache in multiple sclerosis (MS) patients varied widely in recent studies. This study aimed to investigate the 1 year prevalence of headache in MS compared with the general population.

Methods: Population-based case-control study in Germany.

Results: We included 491 patients with definite MS (68% female, mean age 45.3 years, 63.7% relapsing remitting MS, mean Expanded Disability Status Scale (EDSS) 3.2, 106 treated with interferon-beta, 53 with glatiramer acetate, 271 untreated) and 447 age and gender matched controls. Headache was diagnosed with a validated questionnaire according to the International Headache Society Criteria. Headache prevalence was 56.2% (tension type headache 37.2%, migraine 24.6%). Headache prevalence rates did not differ from controls. Headache was not associated with disability or treatment. Trigeminal neuralgia was found in 6.3% of MS cases.

Conclusion: Results suggest that headache in MS patients reflects comorbidity in most conditions.

MeSH terms

  • Adult
  • Aged
  • Case-Control Studies
  • Cross-Sectional Studies
  • Female
  • Glatiramer Acetate
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Interferon-beta / therapeutic use
  • Male
  • Middle Aged
  • Migraine Disorders / complications
  • Migraine Disorders / epidemiology*
  • Multiple Sclerosis / complications*
  • Multiple Sclerosis / drug therapy
  • Peptides / therapeutic use
  • Prevalence
  • Tension-Type Headache / complications
  • Tension-Type Headache / epidemiology*
  • Trigeminal Neuralgia / complications
  • Trigeminal Neuralgia / epidemiology*

Substances

  • Immunosuppressive Agents
  • Peptides
  • Glatiramer Acetate
  • Interferon-beta